Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
biotech
clinical trials
life sciences
national blog main
archive
boston blog main
medical
national top stories
roche
san francisco top stories
alexion pharmaceuticals
alnylam pharmaceuticals
ame cloud ventures
american diabetes association
billy dunn
biogen
boehringer ingelheim
boston
boston top stories
clostridium difficile
colleen cutcliffe
computational biology
deals
diabetes type 2
dicerna pharamceuticals
drug prices
drug pricing
europe top stories
evrysdi
gene therapy
genentech
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
inflammatory bowel disease
investing
ionis pharmaceuticals
khosla ventures
mayo foundation
What
intended
5
×
drug
approved
blood
fda
food
roche
sugar
administration
adults
announced
appetite
approves
atrophy
available
balance
biome
called
caught
causing
company
daily
develop
diabetes
diabetics
dicerna
disease
eli
emergency
evrysdi
eye
eyes
friday
gene
glucagon
green
healthy
help
hepatitis
home
Language
unset
Current search:
intended
×
fda
×
@slashgear.com
2 years ago
Emergency low blood sugar kits recalled over loss of potency
@slashgear.com
2 years ago
FDA approves powerful appetite suppressant for obese adults
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes